Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK MORNING BRIEFING: Glencore Sells Interest In Peru Copper Project

Mon, 14th Apr 2014 07:15

LONDON (Alliance News) - Glencore Xstrata said Monday it has agreed to sell its interest in the Las Bambas copper project in Peru to a Chinese consortium including MMG, Guoxin International Investment Corp and CITIC Metal Co for USD5.85 billion in cash.

The deal is part of an agreement to win Chinese regulatory approval for its USD29 billion takeover of Anglo-Swiss miner Xstrata in May last year

In UK economic news, UK house prices rose to a record high due to the lack of property coming for sale in April, data from the property tracking website Rightmove showed. Asking prices increased at a pace of 7.3% year-on-year in April, the highest since October 2007 and takes it back to pre-credit crunch levels.

Here is what you need to know at the UK market open:

----------

MARKETS

----------

FTSE 100: Down 0.3% at 6,541.79

FTSE 250: Down 0.3% at 15,848.96

AIM ALL-SHARE: Flat at 835.06

----------

Hang Seng: Up 0.1% at 23,034.01

Nikkei 225: Closed down 0.4% at 13,910.16

DJIA: Closed down 0.9% at 16,026.75

S&P 500: Closed down 1.0% at 1815.69

Nasdaq: Closed down 1.3% at 3,999.734

----------

GBP-USD: Down at USD1.6733

EUR-USD: Down at USD1.3848

GOLD: Up at USD1,328.43 per ounce

OIL (Brent): Up at USD108.19 a barrel

(changes since end of previous GMT day)

----------

ECONOMICS AND GENERAL

----------

Monday's Key Economic Events still to come

(all times British Summer Time)

09:00 Italy Consumer Price Index

10:00 EU Industrial Production

13:30 US Retail Sales

15:00 US Business Inventories

17:45 EU ECB Governing Council Member Noyer speech

----------

UK house prices rose to a record high due to the lack of property coming for sale in April, data from the property tracking website Rightmove showed. Asking prices increased at a pace of 7.3% year-on-year in April, the highest since October 2007 and takes it back to pre-credit crunch levels. This follows a 6.8% rise reported for March. The availability of mortgage finance coupled with property shortages exacerbated house prices. The monthly growth held steady at 2.6% in April.

----------

Pro-Russian separatists must lay down their weapons and leave the police stations and administrative buildings in eastern Ukraine they are occupying or a large-scale army operation will be launched against them, Ukraine's president said. The separatists had until 9 am (0600 GMT) to meet the demands, Turchynov said, adding that he had signed a decree promising they would not face prosecution unless they had fired upon Ukrainian security forces.

----------

Syrian President Bashar al-Assad has suggested that the more than three-year-old civil war in his country is tilting in favour of his government. "There is a turning point in the Syrian crisis. Militarily, the army has made successive accomplishments in the war against terrorism," he told a gathering of students in the capital Damascus, according to Syria's official news agency SANA. While al-Assad has faced an unprecedented rebellion since 2011, his troops, backed by fighters from the allied Lebanese Shiite Movement Hezbollah, have in recent months regained opposition-held strongholds, mainly near the border with Lebanon.

----------

Turkey Prime Minister Recep Tayyip Erdogan has lashed out at the head of the Constitutional Court, as tensions rise between the country's chief judicial body and the government. In a veiled reference to Hasim Kilic, the head of the court, Erdogan called for a judge who wants to get involved in politics to "take off your robe." The court this week issued a ruling overturning key parts of a controversial new law that gave the justice minister more power over the judiciary, which civil rights groups argued risked politicizing the justice system.

----------

BROKER RATING CHANGES

---------

UBS CUTS ASHMORE GROUP TO 'NEUTRAL' ('BUY') - TARGET 350 (355) PENCE

----------

TRADERS: NUMIS RAISES JARDINE LLOYD THOMPSON TO 'ADD' ('HOLD')

----------

COMPANIES - FTSE 100

----------

Swiss commodities trader and miner Glencore Xstrata has agreed to sell its interest in the Las Bambas copper project in Peru to a Chinese consortium including MMG, Guoxin International Investment Corp and CITIC Metal Co for USD5.85 billion in cash. The consortium will reimburse all capital expenditure and other costs incurred in developing Las Bambas during the period between January 1 and the closing of the deal. As of the end of March, the capital expenditure and other costs incurred since January 1 stood at about USD400 million. Glencore is selling the Las Bambas project as part of an agreement to win Chinese regulatory approval for its USD29 billion takeover of Anglo-Swiss miner Xstrata in May last year.

----------

UK-based drugmaker GlaxoSmithKline is facing a criminal probe in Poland for allegedly paying bribes to doctors to promote its asthma drug Seretide, BBC Panorama reported on Sunday. According to the report, eleven doctors and one of Glaxo's regional managers have been charged over alleged corruption between 2010 and 2012. The doctors were reportedly bribed to promote Seretide.

----------

Japan-based Orix Corp is considering bidding for Asia-focused lender Standard Chartered's consumer credit unit in Hong Kong, Bloomberg reported citing two people familiar matter. Orix may seek to team up with another investor to acquire PrimeCredit Ltd. Standard Chartered wants to sell the unit for about USD700 million, almost three times book value, and plans to compile a shortlist of potential bidders this month, the report said quoting the people.

----------

COMPANIES - ALL-SHARE AND AIM

----------

Quintain Estates & Developments has created a joint venture with Keystone Developers SA, a subsidiary of Swiss private equity business Keystone Group Holdings, to deliver the next phase of its residential development at Wembley Park. Earlier this year, the London property investment and development specialists secured planning permission for 475 apartments near Wembley Park in North London.

----------

Punch Taverns has brought in an independent corporate restructuring expert to aid long-running discussions over its GBP2.3 billion debt mountain, The Sunday Telegraph reported without saying where it got the information. Dean Merritt, from Talbot Hughes McKillop, is representing the companies that issued Punch?s debt, amid hopes a deal that is agreeable to all lenders and shareholders can be thrashed out by the beginning of next month, the newspaper reports.

----------

Carr's Milling Industries H1 Pretax Profit GBP10.1M Vs GBP9.9M, H1 Revenue GBP214.7M Vs GBP231.6M, Interim Dividend 8.5p Vs 7.75p, To Meet FY Expectations, Says H2 Has Begun Well.

----------

Pentagon Protection is in talks with several parties about providing short term financing or other alternatives, to alleviate constraints on its working capital. Although it has a "relatively health sales pipeline" in each of its divisions, Pentagon said the timing of contract milestones and the conversion of new contracts has led to a deterioration in its cash.

----------

Iodine producer Iofina has started production at two more extraction plants after getting the necessary regulatory approval. In a statement, the company said it has started production at IO#4 and IO#5. The company is constructing a sixth plant based on its wellhead extraction IoSorb technology, IO#6, and expects it to be completed in the second quarter of 2014. However, last month it said that would be the last plant to be built until it has completed a review that it hopes will improve its construction methods and reduce build costs.

----------

32Red has signed a three-year sponsorship agreement with Rangers International Football Club starting from the 2014/2015 season. The deal includes shirt sponsorship, extensive visibility at the club's ground and on its media platforms.

----------

SCISYS has won an operations contract with GMV Aerospace and Defence to provide the mission operations facility of a new geostationary weather satellite. The company said the expected value of the contract is about EUR1.8 million over the next six years, starting in the current reporting period.

----------

MP Evans FY Profit USD22.9M Vs USD21.6M, Raises Dividend To 8.25P, Up 0.25P, Says Price Prospects For Palm Oil, Beef Cattle Remain Favourable

----------

Networkers Intl FY Adjusted Pretax Profit GBP7.1M Vs GBP7.0M, FY Pretax Profit GBP6.3M Vs GBP5.7M, Final Dividend Up 54% To 1.00P, Total Dividend 1.70P Vs 1.25P

----------

Brooks Macdonald Group has acquired Jersey-based DPZ Capital Ltd from DPZ Holdings Ltd for up to GBP13.0 million, including about GBP1.0 million of net current assets, in a move designed to bolster the wealth manager's discretionary funds under management and international presence. The AIM-listed wealth manager said the acquisition increases pro forma discretionary funds under management by GBP360.0 million to GBP6.04 billion.

----------

Real Estate Investors has acquired 33 Bennetts Hill in Birmingham city centre for GBP1.6 million in cash from commercial property consultants GVA, acting on behalf of Royal Bank of Scotland Group PLC. The West Midlands-based property group said the listed building comprises 8,127 square feet and was formerly the original branch of Midlands Bank.

----------

Omega Diagnostics Group says it met expectations for its last financial year, with revenues and adjusted pretax profit ahead of the previous year. The medical diagnostics company expects to post revenues of GBP11.6 million for the year to end-March, up from GBP11.3 million a year earlier, as a strong performance in its food intolerance division offset declines in its allergy and autoimmune division and its infectious disease division. It expects pretax profit, excluding acquisition costs, share based payments and amortisation, to be around GBP1.1 million, up from GBP276,224 in the previous year.

----------

StratMin Global Resources Has Repaid Its GBP750,000 Darwin Convertible Loan Instrument, Says It Wont Draw Down On Second Trache Of Its Darwin Convertible Loan Instrument

----------

Ortac Resources Says Rock Chip Sampling in Eritrea Shows Gold Up To 23 Grammes per Tonne

----------

Monday's Scheduled AGMs/EGMs

Novae Group

----------

By Steve McGrath; steve.mcgrath@alliancenews.com; @stevemcgrath1

Copyright © 2014 Alliance News Limited. All Rights Reserved.

More News
Today 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.